Skip to main content

2025 Canadian Cardiovascular Congress Main banner

6 Views

Electrophysiology

Imaging

Cardiology

Clinical Research

Session Type: Multi-Discipline Session

246 - CHRS / CSCMRI / CSE WORKSHOP- MITRAL VALVE PROLAPSE: WHEN SHOULD I WORRY?

Friday, October 24, 2025

2:00pm - 3:00pm ET

Room:303AB

Target Audience: General: All cardiovascular (clinical and research) health professionals, Electrophysiologists, Magnetic imaging specialist

Co-Chair(s)

Amer Johri, MD (he/him/his)

Professor
CSE
Queen's University
Isabelle Nault, MD (she/her/hers)

Cardiologist
CHRS
Université Laval
Ian Paterson, MD, FRCPC

Cardiologist
CSE, CSCMRI, CardioOncology

Presenter(s)

Léna Rivard, MD,MSc (she/her/hers)

Associate Professor
Institut de Cardiologie de Montréal
Montreal Heart Institute
IR

Idan Roifman, Director of Multimodality Imaging, Reichmann Family Chair for Cardiovascular Research

Cardiologist
CSCMRI
University of Toronto
MT

Maxime Tremblay-Gravel, MD MSc (he/him/his)

Cardiologist
Institut de Cardiologie de Montréal
Université de Montréal

Early Career(s)

MT

Maxime Tremblay-Gravel, MD MSc (he/him/his)

Cardiologist
Institut de Cardiologie de Montréal
Université de Montréal

Planning Committee Member(s)

LL

Laroussi Laila, MD

Cardiologist
Léna Rivard, MD,MSc (she/her/hers)

Associate Professor
Institut de Cardiologie de Montréal
Montreal Heart Institute
MT

Maxime Tremblay-Gravel, MD MSc (he/him/his)

Cardiologist
Institut de Cardiologie de Montréal
Université de Montréal

Learning Objectives:

At the end of this session participants will be able to:

to discuss the clinical features associated with an increased risk of sudden cardiac death (SCD) in mitral valve prolapse (MVP);
review new echographic criteria of malignant MVP; and
review new imaging technology that have, recently, been developed to stratify MVP.